RSS
Affymetrix
Thermo Fisher buys Affymetrix for £898m
Thermo Fisher Scientific has bought Affymetrix, a provider of cellular and genetic analysis products for £898m ($1.3bn) more
© 2018 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.
The essential information source for professionals involved in the formulation, development, manufacturing and supply of drugs and medicines in the pharmaceutical and biopharmaceutical industry.
SUBSCRIBE NOW!